Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
Xiangrui Meng, Junsheng Wang, Jin Xia, Tao Wu, Zhiquan Luo, Yonggui Hong and 24 more
- Rank
- 50 of 1,155
- Percentile
- top 4.4%
- Where
- European Journal of Cancer, 2024
- Citations
- 25
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.